Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Angiodynamics (ANGO) Amortization of Goodwill (2020 - 2024)

Angiodynamics' Amortization of Goodwill history spans 2 years, with the latest figure at $159.5 million for Q1 2024.

For Q1 2024, Amortization of Goodwill changed N/A year-over-year to $159.5 million; the TTM value through May 2020 reached $158.6 million, changed N/A, while the annual FY2024 figure was $159.5 million, 996.13% up from the prior year.
Amortization of Goodwill reached $159.5 million in Q1 2024 per ANGO's latest filing, up from $158.6 million in the prior quarter.
In the past five years, Amortization of Goodwill ranged from a high of $159.5 million in Q1 2024 to a low of $158.6 million in Q2 2020.